Sign inJoin waitlistJoin the waitlist

Rita Mehta

Professor — Division of Hematology and Oncology, Medicine · University of California

Credentials: · ·

History

University of California
Present

Hematology and Medical Oncology
1985–1988
Internal Medicine
1982–1985
M.G.M. Medical College
1978–1982

Research

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Journal of Clinical Oncology · 2016 · 498 citations
Bevacizumab added to neoadjuvant chemotherapy for breast cancer
New England Journal of Medicine · 2012 · 369 citations
Combination anastrozole and fulvestrant in metastatic breast cancer
New England Journal of Medicine · 2012 · First of 11 authors · Corresponding · 291 citations

DH
David Hsiang
17 papers
JB
John A Butler
15 papers
PC
Philip Carpenter
13 papers
RP
Ritesh Parajuli
10 papers · 2 as a fellow
JF
John Fruehauf
9 papers
Shadfar Bahri
9 papers · 1 as a resident
KL
Karen Lane
8 papers
DH
Daniel Hayes
6 papers
Gabriel Hortobagyi
6 papers
JG
Julie Gralow
6 papers
Kathy Albain
6 papers
CB
Choong H Baick
5 papers

Clinical trials

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Principal investigator · Recruiting · Phase 2
University of California, Irvine
2022–2031
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
Principal investigator · Active not recruiting · Phase 2
University of California, Irvine
2015–2036
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases
Principal investigator · Withdrawn
University of California, Irvine
2012–2018
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Principal investigator · Completed · Phase 2
University of California, Irvine
2008–2021